SeaBridge Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,294
| Closed | -$234K | – | 127 |
|
|
2022
Q3 | $234K | Hold |
3,294
| – | – | 0.08% | 125 |
|
|
2022
Q2 | $254K | Hold |
3,294
| – | – | 0.08% | 132 |
|
|
2022
Q1 | $241K | Sell |
3,294
-128
| -4% | -$8.59K | 0.07% | 132 |
|
|
2021
Q4 | $213K | Buy |
+3,422
| New | +$201K | 0.07% | 134 |
|
|
2021
Q3 | – | Sell |
-3,363
| Closed | -$225K | – | 132 |
|
|
2021
Q2 | $225K | Hold |
3,363
| – | – | 0.07% | 127 |
|
|
2021
Q1 | $212K | Buy |
+3,363
| New | +$209K | 0.07% | 129 |
|
|
2020
Q4 | – | Sell |
-3,163
| Closed | -$191K | – | 146 |
|
|
2020
Q3 | $191K | Buy |
3,163
+600
| +23% | +$36.1K | 0.07% | 124 |
|
|
2020
Q2 | $151K | Hold |
2,563
| – | – | 0.06% | 135 |
|
|
2020
Q1 | $143K | Hold |
2,563
| – | – | 0.07% | 135 |
|
|
2019
Q4 | $165K | Buy |
2,563
+430
| +20% | +$24.6K | 0.06% | 134 |
|
|
2019
Q3 | $108K | Buy |
2,133
+500
| +31% | +$23.5K | 0.04% | 142 |
|
|
2019
Q2 | $74K | Buy |
1,633
+700
| +75% | +$32.6K | 0.02% | 164 |
|
|
2019
Q1 | $45K | Buy |
933
+300
| +47% | +$14.9K | 0.02% | 175 |
|
|
2018
Q4 | $33K | Hold |
633
| – | – | 0.01% | 185 |
|
|
2018
Q3 | $39K | Hold |
633
| – | – | 0.01% | 175 |
|
|
2018
Q2 | $35K | Hold |
633
| – | – | 0.01% | 182 |
|
|
2018
Q1 | $40K | Hold |
633
| – | – | 0.01% | 171 |
|
|
2017
Q4 | $39K | Buy |
633
+333
| +111% | +$20.8K | 0.01% | 181 |
|
|
2017
Q3 | $19K | Hold |
300
| – | – | ﹤0.01% | 204 |
|
|
2017
Q2 | $17K | Hold |
300
| – | – | ﹤0.01% | 209 |
|
|
2017
Q1 | $16K | Hold |
300
| – | – | ﹤0.01% | 216 |
|
|
2016
Q4 | $18K | Hold |
300
| – | – | ﹤0.01% | 192 |
|
|
2016
Q3 | $16K | Hold |
300
| – | – | ﹤0.01% | 200 |
|
|
2016
Q2 | $22K | Hold |
300
| – | – | 0.01% | 196 |
|
|
2016
Q1 | $19K | Hold |
300
| – | – | ﹤0.01% | 196 |
|
|
2015
Q4 | $21K | Hold |
300
| – | – | ﹤0.01% | 194 |
|
|
2015
Q3 | $18K | Hold |
300
| – | – | ﹤0.01% | 197 |
|
|
2015
Q2 | $20K | Hold |
300
| – | – | ﹤0.01% | 189 |
|
|
2015
Q1 | $19K | Hold |
300
| – | – | ﹤0.01% | 192 |
|
|
2014
Q4 | $18K | Hold |
300
| – | – | ﹤0.01% | 200 |
|
|
2014
Q3 | $15K | Hold |
300
| – | – | ﹤0.01% | 181 |
|
|
2014
Q2 | $15K | Hold |
300
| – | – | ﹤0.01% | 196 |
|
|
2014
Q1 | $16K | Buy |
+300
| New | +$16K | ﹤0.01% | 185 |
|
Other funds holding BMY
AWA
SeaBridge Investment Advisors's BMY Position: Q4 2022 in Review
SeaBridge Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 3,294 shares — an estimated $234K sold.
SeaBridge Investment Advisors first reported a position in BMY in Q1 2014 and held it in 33 quarters. The position peaked at $254K in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- SeaBridge Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- SeaBridge Investment Advisors sold 3,294 Bristol-Myers Squibb shares in Q4 2022, an estimated $234K.
- SeaBridge Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 33 quarters.
- SeaBridge Investment Advisors's Bristol-Myers Squibb position peaked at $254K in Q2 2022.
- 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on SeaBridge Investment Advisors's 13F filing for Q4 2022, filed 19 Jan 2023.